Loading organizations...
§ Venture Capital · Asia-Pacific, USA, Europe
Learn which startups Takeda Digital Ventures invests in, what size check sizes they write, and who their partners are (e.g. Christophe Weber).
Key people at Takeda Digital Ventures.
Takeda Digital Ventures operates as the corporate venture capital arm of Takeda Pharmaceutical Company, strategically investing in digital health companies. It focuses on identifying and supporting early to growth-stage businesses that leverage digital capabilities to enhance patient outcomes and improve healthcare delivery across diverse therapeutic areas. The firm’s approach involves fostering innovation to develop focused, patient-centric solutions.
The venture group was established in 2018 by Takeda Pharmaceutical Company itself, reflecting a strategic imperative to embrace digital transformation within the pharmaceutical landscape. This initiative stemmed from the recognition that integrating advanced digital solutions is crucial for addressing unmet medical needs and creating more efficient, effective patient care pathways. Its formation underscores a commitment to external innovation alongside internal research and development efforts.
Takeda Digital Ventures partners with companies developing digital solutions, ultimately aiming to benefit patients by optimizing their entire healthcare journey. The long-term vision centers on driving a digital evolution across the pharmaceutical and healthcare sectors, facilitating the creation and adoption of technologies that lead to improved patient experiences and better overall health outcomes.
Key people at Takeda Digital Ventures.
Takeda Digital Ventures operates as the corporate venture capital arm of Takeda Pharmaceutical Company, strategically investing in digital health companies. It focuses on identifying and supporting early to growth-stage businesses that leverage digital capabilities to enhance patient outcomes and improve healthcare delivery across diverse therapeutic areas. The firm’s approach involves fostering innovation to develop focused, patient-centric solutions.
The venture group was established in 2018 by Takeda Pharmaceutical Company itself, reflecting a strategic imperative to embrace digital transformation within the pharmaceutical landscape. This initiative stemmed from the recognition that integrating advanced digital solutions is crucial for addressing unmet medical needs and creating more efficient, effective patient care pathways. Its formation underscores a commitment to external innovation alongside internal research and development efforts.
Takeda Digital Ventures partners with companies developing digital solutions, ultimately aiming to benefit patients by optimizing their entire healthcare journey. The long-term vision centers on driving a digital evolution across the pharmaceutical and healthcare sectors, facilitating the creation and adoption of technologies that lead to improved patient experiences and better overall health outcomes.
Takeda Digital Ventures has 3 tracked investments across 3 companies. The latest tracked deal is $50.0M Series B in aptihealth in November 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 19, 2021 | aptihealth | $50.0M Series B | — | Claritas Capital, Olive Tree Ventures, Pivotal Life Sciences, Vista Equity Partners, What IF Ventures |
| May 3, 2021 | SEQSTER | $12.0M Series A | Timothy O'donnell | Anne Wojcicki |
| Jan 1, 2021 | Aspen RxHealth | $23.0M Series B | Bessemer Venture Partners | David Ibnale, Collaborative Seed & Growth Partners, Eniac Ventures, Next Play Ventures, Obvious Ventures, Remus Capital, DRX Capital, Flare Capital Partners, Humana, McKesson Ventures |